Bibliographic information
GuidelineWHO Guidelines for malaria, 14 March 2023
Year of Publication2023
Issuing InstitutionWHO
Recommendation
Maintained
Short-course standard high-dose primaquine treatment: To prevent relapse, WHO recommends against an additional treatment option of using primaquine 1.0 mg/kg/ day for seven days to treat P. vivax or P. ovale malaria.
Recommended against
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO guidelines for malaria, 25 November 2022.
Year2022
InstitutionWorld Health Organization